Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Psittaciformes; Psittacidae; Myiopsitta,
Latin Name:
Myiopsitta monachus
Tested tissues: PBMC,
Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
---|---|---|---|---|---|---|
Vthunter_0060 | 2021.04 | iDrop | PBMC | Normal | 1958 | Link |
Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
---|---|---|
Influenza A virus | ||
Simian rotavirus A strain RRV |
PBMC-Macrophage : 97.72% ; PBMC-T cells : 95.71% ; PBMC-B cells : 93.48% ; PBMC-Platelets : 86.59% ; PBMC-Erythroid Progenitors : 66.67% ; PBMC-Macrophage : 86.93% ; PBMC-Platelets : 73.17% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 51.59% ; PBMC-T cells : 51.43% ; PBMC-Platelets : 68.29% ; PBMC-Macrophage : 18.27% ; PBMC-T cells : 12.86% ; PBMC-B cells : 10.87% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-Platelets : 68.29% ; PBMC-Macrophage : 19.42% ; PBMC-T cells : 15.71% ; PBMC-B cells : 14.13% ; PBMC-Monocyte : 8.73% ; PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; |
|
Venezuelan equine encephalitis virus |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; |
|
Sindbis virus |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; |
|
Classical swine fever virus |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; |
|
Adeno-associated virus - 2 |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; PBMC-Macrophage : 86.93% ; PBMC-Platelets : 73.17% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 51.59% ; PBMC-T cells : 51.43% ; PBMC-Macrophage : 20.88% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-T cells : 12.86% ; PBMC-B cells : 9.78% ; PBMC-Platelets : 7.32% ; |
|
Adeno-associated virus 9 |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; |
|
Adeno-associated virus - 8 |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; |
|
Adeno-associated virus - 3 |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; |
|
Dengue virus |
PBMC-B cells : 92.39% ; PBMC-Macrophage : 92.20% ; PBMC-T cells : 84.29% ; PBMC-Platelets : 64.63% ; PBMC-Erythroid Progenitors : 58.33% ; PBMC-Macrophage : 16.94% ; PBMC-T cells : 2.86% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Monocyte : 0.79% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-B cells : 2.17% ; PBMC-Macrophage : 2.16% ; PBMC-T cells : 1.43% ; PBMC-Monocyte : 0.00% ; |
|
Echovirus E8 | ||
Equid alphaherpesvirus 1 | ||
Mammalian orthoreovirus |
PBMC-Macrophage : 86.93% ; PBMC-Platelets : 73.17% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 51.59% ; PBMC-T cells : 51.43% ; |
|
Human metapneumovirus |
PBMC-Macrophage : 86.93% ; PBMC-Platelets : 73.17% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 51.59% ; PBMC-T cells : 51.43% ; |
|
Human betaherpesvirus 5 |
PBMC-Macrophage : 86.93% ; PBMC-Platelets : 73.17% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 51.59% ; PBMC-T cells : 51.43% ; PBMC-Platelets : 68.29% ; PBMC-Macrophage : 18.27% ; PBMC-T cells : 12.86% ; PBMC-B cells : 10.87% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; |
|
Echovirus E1 | ||
Human parvovirus B19 |
PBMC-Macrophage : 86.93% ; PBMC-Platelets : 73.17% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 51.59% ; PBMC-T cells : 51.43% ; |
|
Human rotavirus strain WA | ||
Human gammaherpesvirus 4 | ||
Foot-and-mouth disease virus |
PBMC-Macrophage : 86.93% ; PBMC-Platelets : 73.17% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 51.59% ; PBMC-T cells : 51.43% ; PBMC-Platelets : 68.29% ; PBMC-Macrophage : 18.27% ; PBMC-T cells : 12.86% ; PBMC-B cells : 10.87% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; PBMC-Monocyte : 1.59% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.76% ; PBMC-T cells : 0.00% ; |
|
Chikungunya virus |
PBMC-Macrophage : 83.95% ; PBMC-Platelets : 59.76% ; PBMC-T cells : 57.14% ; PBMC-B cells : 56.52% ; PBMC-Monocyte : 47.62% ; |
|
Hepacivirus C |
PBMC-T cells : 74.29% ; PBMC-Macrophage : 64.09% ; PBMC-B cells : 45.65% ; PBMC-Platelets : 29.27% ; PBMC-Erythroid Progenitors : 25.00% ; PBMC-Erythroid Progenitors : 66.67% ; PBMC-B cells : 34.78% ; PBMC-T cells : 17.14% ; PBMC-Macrophage : 13.77% ; PBMC-Platelets : 10.98% ; PBMC-Macrophage : 14.47% ; PBMC-Platelets : 8.54% ; PBMC-B cells : 2.17% ; PBMC-Monocyte : 1.59% ; PBMC-T cells : 1.43% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-B cells : 2.17% ; PBMC-Macrophage : 2.16% ; PBMC-T cells : 1.43% ; PBMC-Monocyte : 0.00% ; PBMC-Platelets : 4.88% ; PBMC-Macrophage : 4.31% ; PBMC-T cells : 1.43% ; PBMC-B cells : 1.09% ; PBMC-Monocyte : 0.79% ; PBMC-Macrophage : 0.32% ; PBMC-Monocyte : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-T cells : 0.00% ; |
|
Bovine leukemia virus |
PBMC-Macrophage : 74.24% ; PBMC-B cells : 44.57% ; PBMC-Monocyte : 34.92% ; PBMC-Platelets : 31.71% ; PBMC-T cells : 27.14% ; |
|
Feline immunodeficiency virus | ||
Human immunodeficiency virus 2 | ||
Human immunodeficiency virus 1 | ||
Lassa mammarenavirus |
PBMC-Macrophage : 70.75% ; PBMC-Platelets : 34.15% ; PBMC-T cells : 28.57% ; PBMC-Monocyte : 26.19% ; PBMC-B cells : 25.00% ; PBMC-Macrophage : 16.94% ; PBMC-T cells : 2.86% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Monocyte : 0.79% ; PBMC-Macrophage : 15.23% ; PBMC-Monocyte : 1.59% ; PBMC-T cells : 1.43% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Platelets : 0.00% ; |
|
West Nile virus | ||
Human parechovirus 1 | ||
Hantaan orthohantavirus |
PBMC-Platelets : 68.29% ; PBMC-Macrophage : 18.27% ; PBMC-T cells : 12.86% ; PBMC-B cells : 10.87% ; PBMC-Erythroid Progenitors : 8.33% ; |
|
Human gammaherpesvirus 8 |
PBMC-Platelets : 68.29% ; PBMC-Macrophage : 18.27% ; PBMC-T cells : 12.86% ; PBMC-B cells : 10.87% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; PBMC-Macrophage : 0.19% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; |
|
Coxsackievirus A9 |
PBMC-Platelets : 68.29% ; PBMC-Macrophage : 18.27% ; PBMC-T cells : 12.86% ; PBMC-B cells : 10.87% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; PBMC-Monocyte : 1.59% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.76% ; PBMC-T cells : 0.00% ; |
|
Canine parvovirus |
PBMC-Erythroid Progenitors : 66.67% ; PBMC-B cells : 34.78% ; PBMC-T cells : 17.14% ; PBMC-Macrophage : 13.77% ; PBMC-Platelets : 10.98% ; |
|
Feline panleukopenia virus |
PBMC-Erythroid Progenitors : 66.67% ; PBMC-B cells : 34.78% ; PBMC-T cells : 17.14% ; PBMC-Macrophage : 13.77% ; PBMC-Platelets : 10.98% ; |
|
Mouse mammary tumor virus |
PBMC-Erythroid Progenitors : 66.67% ; PBMC-B cells : 34.78% ; PBMC-T cells : 17.14% ; PBMC-Macrophage : 13.77% ; PBMC-Platelets : 10.98% ; |
|
Argentinian mammarenavirus |
PBMC-Erythroid Progenitors : 66.67% ; PBMC-B cells : 34.78% ; PBMC-T cells : 17.14% ; PBMC-Macrophage : 13.77% ; PBMC-Platelets : 10.98% ; |
|
Guanarito mammarenavirus |
PBMC-Erythroid Progenitors : 66.67% ; PBMC-B cells : 34.78% ; PBMC-T cells : 17.14% ; PBMC-Macrophage : 13.77% ; PBMC-Platelets : 10.98% ; |
|
Machupo mammarenavirus |
PBMC-Erythroid Progenitors : 66.67% ; PBMC-B cells : 34.78% ; PBMC-T cells : 17.14% ; PBMC-Macrophage : 13.77% ; PBMC-Platelets : 10.98% ; |
|
Severe acute respiratory syndrome coronavirus 2 | ||
Enterovirus A71 | ||
Coxsackievirus A16 |
PBMC-Macrophage : 47.27% ; PBMC-T cells : 15.71% ; PBMC-B cells : 10.87% ; PBMC-Platelets : 6.10% ; PBMC-Monocyte : 5.56% ; |
|
Porcine reproductive and respiratory syndrome virus | ||
Human papillomavirus type 16 | ||
Japanese encephalitis virus |
PBMC-Platelets : 30.49% ; PBMC-B cells : 7.61% ; PBMC-T cells : 7.14% ; PBMC-Macrophage : 5.96% ; PBMC-Monocyte : 2.38% ; |
|
Ebola virus |
PBMC-Macrophage : 29.12% ; PBMC-Platelets : 12.20% ; PBMC-B cells : 8.70% ; PBMC-Monocyte : 7.94% ; PBMC-T cells : 2.86% ; PBMC-Macrophage : 16.94% ; PBMC-T cells : 2.86% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Monocyte : 0.79% ; PBMC-Macrophage : 6.79% ; PBMC-Platelets : 6.10% ; PBMC-T cells : 2.86% ; PBMC-B cells : 2.17% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Vesicular stomatitis virus |
PBMC-Macrophage : 27.41% ; PBMC-B cells : 25.00% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 13.41% ; PBMC-T cells : 11.43% ; |
|
Human alphaherpesvirus 1 |
PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; PBMC-B cells : 2.17% ; PBMC-Macrophage : 1.08% ; PBMC-Monocyte : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-T cells : 0.00% ; PBMC-Monocyte : 1.59% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.76% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human mastadenovirus C |
PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Macrophage : 0.38% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; |
|
Coxsackievirus B1 |
PBMC-Macrophage : 18.91% ; PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 12.20% ; PBMC-Monocyte : 7.94% ; PBMC-B cells : 7.61% ; PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-Platelets : 0.00% ; PBMC-B cells : 0.00% ; PBMC-Monocyte : 1.59% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.76% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human mastadenovirus B | ||
Lymphocytic choriomeningitis mammarenavirus | ||
Zika virus |
PBMC-Macrophage : 16.94% ; PBMC-T cells : 2.86% ; PBMC-Platelets : 1.22% ; PBMC-B cells : 1.09% ; PBMC-Monocyte : 0.79% ; |
|
Marburg marburgvirus | ||
Andes orthohantavirus |
PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 1.22% ; PBMC-Monocyte : 0.00% ; PBMC-B cells : 0.00% ; PBMC-T cells : 0.00% ; |
|
Sin Nombre orthohantavirus |
PBMC-Erythroid Progenitors : 16.67% ; PBMC-Platelets : 1.22% ; PBMC-Monocyte : 0.00% ; PBMC-B cells : 0.00% ; PBMC-T cells : 0.00% ; |
|
Gibbon ape leukemia virus | ||
Simian sarcoma-associated virus |
PBMC-Erythroid Progenitors : 16.67% ; PBMC-T cells : 14.29% ; PBMC-Macrophage : 11.23% ; PBMC-Platelets : 8.54% ; PBMC-B cells : 7.61% ; |
|
Feline leukemia virus strain B/lambda-B1 | ||
Xenotropic murine leukemia virus |
PBMC-Macrophage : 16.43% ; PBMC-B cells : 9.78% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-T cells : 7.14% ; PBMC-Platelets : 4.88% ; |
|
Polytropic murine leukemia virus |
PBMC-Macrophage : 16.43% ; PBMC-B cells : 9.78% ; PBMC-Erythroid Progenitors : 8.33% ; PBMC-T cells : 7.14% ; PBMC-Platelets : 4.88% ; |
|
Simian immunodeficiency virus |
PBMC-T cells : 15.71% ; PBMC-Platelets : 2.44% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.95% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human betaherpesvirus 7 |
PBMC-T cells : 15.71% ; PBMC-Platelets : 2.44% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.95% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Latino mammarenavirus |
PBMC-Macrophage : 15.23% ; PBMC-Monocyte : 1.59% ; PBMC-T cells : 1.43% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Oliveros mammarenavirus |
PBMC-Macrophage : 15.23% ; PBMC-Monocyte : 1.59% ; PBMC-T cells : 1.43% ; PBMC-B cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human alphaherpesvirus 3 |
PBMC-Macrophage : 14.02% ; PBMC-T cells : 11.43% ; PBMC-Monocyte : 5.56% ; PBMC-B cells : 4.35% ; PBMC-Platelets : 3.66% ; |
|
Varicella Zoster Virus |
PBMC-Macrophage : 14.02% ; PBMC-T cells : 11.43% ; PBMC-Monocyte : 5.56% ; PBMC-B cells : 4.35% ; PBMC-Platelets : 3.66% ; |
|
Feline leukemia virus strain C/FA27 |
PBMC-Platelets : 12.20% ; PBMC-Macrophage : 9.77% ; PBMC-T cells : 8.57% ; PBMC-B cells : 5.43% ; PBMC-Monocyte : 2.38% ; |
|
Respiratory syncytial virus |
PBMC-T cells : 11.43% ; PBMC-Platelets : 6.10% ; PBMC-Macrophage : 1.65% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; |
|
Amphotropic murine leukemia virus |
PBMC-Macrophage : 9.33% ; PBMC-B cells : 6.52% ; PBMC-Platelets : 3.66% ; PBMC-T cells : 2.86% ; PBMC-Monocyte : 0.79% ; |
|
Coxsackievirus A10 |
PBMC-Erythroid Progenitors : 8.33% ; PBMC-Monocyte : 3.97% ; PBMC-Macrophage : 3.24% ; PBMC-T cells : 1.43% ; PBMC-B cells : 1.09% ; |
|
Middle East respiratory syndrome-related coronavirus |
PBMC-Macrophage : 8.31% ; PBMC-Platelets : 4.88% ; PBMC-Monocyte : 1.59% ; PBMC-T cells : 1.43% ; PBMC-B cells : 1.09% ; |
|
Phocine morbillivirus |
PBMC-B cells : 4.35% ; PBMC-Platelets : 2.44% ; PBMC-T cells : 1.43% ; PBMC-Macrophage : 0.19% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Rinderpest morbillivirus |
PBMC-B cells : 4.35% ; PBMC-Platelets : 2.44% ; PBMC-T cells : 1.43% ; PBMC-Macrophage : 0.19% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Measles morbillivirus |
PBMC-B cells : 4.35% ; PBMC-Platelets : 2.44% ; PBMC-T cells : 1.43% ; PBMC-Macrophage : 0.19% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Canine morbillivirus |
PBMC-B cells : 4.35% ; PBMC-Platelets : 2.44% ; PBMC-T cells : 1.43% ; PBMC-Macrophage : 0.19% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Coxsackievirus B4 |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human mastadenovirus A |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human mastadenovirus D |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Coxsackievirus B3 |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human mastadenovirus F |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human mastadenovirus E |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Coxsackievirus B2 |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Nipah henipavirus |
PBMC-T cells : 2.86% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.51% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; |
|
Coxsackievirus B6 |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Hendra henipavirus |
PBMC-T cells : 2.86% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.51% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; |
|
Coxsackievirus B5 |
PBMC-T cells : 2.86% ; PBMC-Macrophage : 1.90% ; PBMC-Monocyte : 0.79% ; PBMC-B cells : 0.00% ; PBMC-Platelets : 0.00% ; |
|
JC polyomavirus |
PBMC-Platelets : 2.44% ; PBMC-B cells : 2.17% ; PBMC-Macrophage : 0.95% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; |
|
Rabies lyssavirus |
PBMC-Platelets : 2.44% ; PBMC-T cells : 1.43% ; PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.06% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Bovine alphaherpesvirus 1 |
PBMC-B cells : 2.17% ; PBMC-Macrophage : 1.08% ; PBMC-T cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; |
|
Hepatitis E virus |
PBMC-B cells : 2.17% ; PBMC-Platelets : 1.22% ; PBMC-Macrophage : 0.06% ; PBMC-T cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Human alphaherpesvirus 2 |
PBMC-B cells : 2.17% ; PBMC-Macrophage : 1.08% ; PBMC-T cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; |
|
Suid alphaherpesvirus 1 |
PBMC-B cells : 2.17% ; PBMC-Macrophage : 1.08% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-T cells : 0.00% ; PBMC-Monocyte : 0.00% ; |
|
Ecotropic murine leukemia virus |
PBMC-B cells : 2.17% ; PBMC-Platelets : 1.22% ; PBMC-Macrophage : 0.13% ; PBMC-T cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; |
|
Jaagsiekte sheep retrovirus |
PBMC-T cells : 1.43% ; PBMC-Macrophage : 0.95% ; PBMC-Monocyte : 0.79% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Human betaherpesvirus 6B |
PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.25% ; PBMC-T cells : 0.00% ; PBMC-Erythroid Progenitors : 0.00% ; PBMC-Monocyte : 0.00% ; |
|
Enterovirus D68 |
PBMC-B cells : 1.09% ; PBMC-Macrophage : 0.32% ; PBMC-Monocyte : 0.00% ; PBMC-T cells : 0.00% ; PBMC-Platelets : 0.00% ; |